Prevalence and Predictors of Overweight and Obesity in Patients with Pituitary Dysfunctions

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|16|4|249-253

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.4, 2017-02, pp. : 249-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rimonabant relieves obesity burden in overweight patients

By  

Inpharma, Vol. 1, Iss. 1526, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Relationship between Cardiovascular Risk Indicators and Types of Obesity in Overweight and Obese Women

By Cikim AS   Ozbey N   Orhan Y  

The Journal of International Medical Research, Vol. 32, Iss. 3, 2004-05 ,pp. : 268-273

Field House Publishing

Access to resources Recommend Favorite

Overweight, Obesity and Thyroid Cancer Risk: a Meta-analysis of Cohort Studies

By Zhao ZG   Guo XG   Ba CX   Wang W   Yang YY   Wang J   Cao HY  

The Journal of International Medical Research, Vol. 40, Iss. 6, 2012-11 ,pp. : 2041-2050

Field House Publishing

Access to resources Recommend Favorite

Timing of school meals as a predisposing factor for childhood overweight and obesity

By  

NUTRITION AND DIETETICS, Vol. 73, Iss. 2, 2016-04 ,pp. : 190-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rimonabant: a guide to its use in obese and overweight patients

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 8, 2007-08 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite